PNC Financial Services Group’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
CF
PVM
NI
PNC Financial Services Group's HCAT Position: Q2 2026 in Review
PNC Financial Services Group reduced its Health Catalyst (HCAT) stake by 59% in Q2 2026, selling an estimated $4.74K and leaving 2,314 shares worth $4.61K. The position accounts for ﹤0.01% of the portfolio, ranked #4419.
PNC Financial Services Group first reported a position in HCAT in Q3 2019 and has held it in 28 quarters since. The position peaked at $253K in Q2 2021. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.
- PNC Financial Services Group held 2,314 shares of Health Catalyst worth $4.61K as of Q2 2026.
- PNC Financial Services Group sold 3,286 Health Catalyst shares in Q2 2026, an estimated $4.74K.
- Health Catalyst made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4419 holding.
- PNC Financial Services Group first reported a position in Health Catalyst in Q3 2019 and has held it in 28 quarters since.
- PNC Financial Services Group's Health Catalyst position peaked at $253K in Q2 2021.
- 126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.